We recently published a list of 10 Hottest Mega-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...

Boston Scientific Corp (BSX) stock saw a modest uptick, ending the day at $95.65 which represents a slight increase of $1.04 or 1.10% from the prior close of $94.61. The stock opened at $95.08 and ...

Boston Scientific Corp (BSX) stock saw a decline, ending the day at $94.88 which represents a decrease of $-1.07 or -1.12% from the prior close of $95.95. The stock opened at $95.48 and touched a low ...

We recently compiled a list of the Billionaire Israel Englander’s Top 10 Stock Picks Heading Into 2025. In this article, we ...

Boston Scientific BSX is gaining from new product launches and accretive acquisitions. Yet, unfavorable currency movement and ...

Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

On Oct. 10, Boston Scientific sent an urgent medical device ... Healthcare & Pharmaceuticalscategory Lilly forecasts weak fourth-quarter sales of weight-loss drug, shares slump 3:14 PM UTC ...

AngioDynamics' fiscal Q2'25 results exceeded expectations, with Med Tech growing 25% and delivering better gross margins. See ...

David Schnur Associates is partnering with Randy Earls and Laura Evenson of Bunting, Earls and Associates to expand U.S.

Boston Scientific said the Intracept procedure was expected to generate over $100 million in sales in 2024. Relievant also was one of the biggest customers of the University of North Texas ...